CSS Industries Inc. (NYSE:CSS) shares moved down -0.97% in last trading session and ended the day at $28.65. CSS Gross Margin is 32.40% and its has a return on assets of 5.30%. CSS Industries Inc. (NYSE:CSS) quarterly performance is 3.66%.
CSS Industries, Inc. (NYSE:CSS) announced the declaration of a quarterly dividend of eighteen cents per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2015 to stockholders of record at the close of business on December 1, 2015.
BG Medicine, Inc. (NASDAQ:BGMD) ended the last trading day at $0.68. Company weekly volatility is calculated as 8.69%. BG Medicine, Inc. (NASDAQ:BGMD) showed a weekly performance of 11.48%.
On December 3, 2015, BG Medicine, Inc. (NASDAQ:BGMD) notified Deloitte & Touche LLP (“Deloitte”), who had been serving as the Company’s independent registered public accounting firm, of the Company’s decision to dismiss Deloitte. The reports of Deloitte on the consolidated financial statements of the Company as of and for the fiscal years ended December 31, 2013 and December 31, 2014 contained no adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except in its report dated March 31, 2015 for the fiscal year ended December 31, 2014 and in its report dated March 27, 2014 for the fiscal year ended December 31, 2013, which reports express an unqualified opinion on the consolidated financial statements but include explanatory paragraphs relating to substantial doubt about the Company’s ability to continue as a going concern.
On 04 December, Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares increased 1.94% and was closed at $7.34. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) year to date (YTD) performance is 1.66%.
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, presented at the 27th Annual Piper Jaffray Healthcare Conference on December 1, 2015 at The New York Palace Hotel in New York, NY.
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) shares moved down -0.22% in last trading session and ended the day at $8.96. VNDA Gross Margin is 80.70% and its has a return on assets of 21.50%. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) quarterly performance is -26.01%.
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) Dr. Polymeropoulos delivered a corporate presentation at the 27th Annual Piper Jaffray Healthcare Conference in New York City on Wednesday, December 2, 2015 at 2:30 p.m. Eastern Time.
Celladon Corporation (NASDAQ:CLDN) caters to the Healthcare space. Its weekly performance is -0.69%. On the last day of trading company shares ended up at $1.44. Celladon Corporation (NASDAQ:CLDN) distance from 50-day simple moving average (SMA50) is 4.63%.
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Celladon Corporation (NASDAQ: CLDN) breached their fiduciary duties in connection with the proposed merger of the Company with Eiger BioPharmaceuticals, Inc.
Leave a Reply